[go: up one dir, main page]

EA201301197A1 - Композиция энтакапона - Google Patents

Композиция энтакапона

Info

Publication number
EA201301197A1
EA201301197A1 EA201301197A EA201301197A EA201301197A1 EA 201301197 A1 EA201301197 A1 EA 201301197A1 EA 201301197 A EA201301197 A EA 201301197A EA 201301197 A EA201301197 A EA 201301197A EA 201301197 A1 EA201301197 A1 EA 201301197A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
entacapone
entakapona
pvp
sds
Prior art date
Application number
EA201301197A
Other languages
English (en)
Other versions
EA025627B1 (ru
Inventor
Вэй-Хуа Хао
Цзон-Цзин Ван
Хуи-Юнь Чэн
Original Assignee
Иннофармакс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иннофармакс, Инк. filed Critical Иннофармакс, Инк.
Publication of EA201301197A1 publication Critical patent/EA201301197A1/ru
Publication of EA025627B1 publication Critical patent/EA025627B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Композиция энтакапона, содержащая энтакапон или его фармацевтически приемлемые соли, ПВП К30 и ДСН, раскрыта в настоящем изобретении, в котором отношение массовое соотношение энтакапона:ПВП К30:ДСН составляет 1:0,05 ~ 0,6:0,06 ~ 0,1. Изобретение также раскрывает препаративный способ и применение композиции энтакапона.
EA201301197A 2011-04-26 2011-04-26 Композиция для лечения болезни паркинсона EA025627B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2011/073297 WO2012145893A1 (zh) 2011-04-26 2011-04-26 安它可朋组合物

Publications (2)

Publication Number Publication Date
EA201301197A1 true EA201301197A1 (ru) 2014-02-28
EA025627B1 EA025627B1 (ru) 2017-01-30

Family

ID=47071548

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301197A EA025627B1 (ru) 2011-04-26 2011-04-26 Композиция для лечения болезни паркинсона

Country Status (11)

Country Link
US (1) US20140120166A1 (ru)
EP (1) EP2702991A4 (ru)
JP (1) JP5855230B2 (ru)
KR (1) KR101807907B1 (ru)
CN (1) CN103476406B (ru)
AU (1) AU2011366717B2 (ru)
BR (1) BR112013027219A2 (ru)
CA (1) CA2833443C (ru)
EA (1) EA025627B1 (ru)
MX (1) MX2013012429A (ru)
WO (1) WO2012145893A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101974752B1 (ko) * 2017-12-31 2019-09-05 황혜미 욕창 치료용 크림 및 이를 제조하는 방법
AU2021235850A1 (en) * 2020-03-13 2022-10-06 BIAL - PORTELA & Cª, S.A. Micronised opicapone

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
FI109453B (fi) * 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
JP4334869B2 (ja) * 2000-12-01 2009-09-30 協和発酵キリン株式会社 溶解性または経口吸収性の改善された組成物
EP1448169A1 (en) * 2001-11-07 2004-08-25 Fujisawa Pharmaceutical Co., Ltd. Method for improving dissolution of poorly dispersible medicaments
CN1275593C (zh) * 2004-02-13 2006-09-20 马晶 一种枸橼酸他莫昔芬分散片及其制法
SI1896006T1 (sl) * 2005-06-08 2010-02-26 Orion Corp Postopek za izdelavo granul, ki vsebujejo entakapon, za oralne odmerne oblike
WO2007069274A2 (en) * 2005-11-09 2007-06-21 Torrent Pharmaceuticals Limited Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
WO2008081268A2 (en) * 2006-12-27 2008-07-10 Wockhardt Research Centre Pharmaceutical compositions of entacapone
JP5466179B2 (ja) * 2008-02-06 2014-04-09 ウォックハート リサーチ センター 生物学的利用能が改善されたエンタカポン、レボドパ及びカルビドパの医薬組成物
AU2009283813B2 (en) * 2008-08-22 2015-02-19 Wockhardt Research Centre An extended release pharmaceutical composition of entacapone or salts thereof
WO2011075912A1 (zh) * 2009-12-25 2011-06-30 台湾东洋药品工业股份有限公司 治疗帕金森氏症的医药组合物及其制备方法

Also Published As

Publication number Publication date
CA2833443A1 (en) 2012-11-01
EP2702991A4 (en) 2015-02-18
WO2012145893A1 (zh) 2012-11-01
KR101807907B1 (ko) 2017-12-11
EA025627B1 (ru) 2017-01-30
CA2833443C (en) 2017-11-07
KR20140024879A (ko) 2014-03-03
AU2011366717B2 (en) 2017-06-15
CN103476406A (zh) 2013-12-25
EP2702991A1 (en) 2014-03-05
BR112013027219A2 (pt) 2016-12-27
US20140120166A1 (en) 2014-05-01
JP5855230B2 (ja) 2016-02-09
MX2013012429A (es) 2013-12-06
JP2014512395A (ja) 2014-05-22
CN103476406B (zh) 2017-05-24
AU2011366717A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
CY1125436T1 (el) Αναστολεις dna-pk
BR112015000561A2 (pt) inibidores de irak e usos dos mesmos
EA201492216A1 (ru) Ингибиторы бромодомена и их применение
CY1119163T1 (el) Αμιδια πυριδονης ως ρυθμιστες διαυλων νατριου
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
CL2015001358A1 (es) Potenciadores del cftr deuterados
BR112014013108A2 (pt) compostos tricíclicos fundidos como inibidores da quinase raf
MX2015011898A (es) Compuestos de pirazolo y usos de los mismos.
HK1220355A1 (zh) Mk2抑制劑和其用途
PH12014501273A1 (en) Intranasal dexmedetomidine compositions and methods of use thereof
EA201591420A1 (ru) Гетероарильные соединения и их применение
CY1117471T1 (el) Αμιδια πυρρολοπυραζινης-σπειροκυκλικης πιπεριδινης ως ρυθμιστες διαυλων ιοντος
WO2012174487A3 (en) Bromodomain inhibitors and uses thereof
WO2012151512A3 (en) Bromodomain inhibitors and uses thereof
MX2016003823A (es) Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma.
MX2015010921A (es) Compuestos de carbazol utiles como inhibidores de bromodominio.
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
EA201691044A1 (ru) Новый октагидро-циклобута[1,2-c;3,4-c']дипиррол-2-ил
PH12016500347A1 (en) Triazolopyridine compounds, compositions and methods of use thereof
UA115357C2 (uk) Похідні піридин-4-ілу
BR112015028824A2 (pt) composição de tensoativo concentrada
MA37650A1 (fr) Forme amorphe d'un composé pyrimidinyl-cyclopentane inhibiteur de akt, compositions et procédés de celle-ci
IN2014DN11078A (ru)
EA201491300A1 (ru) Композиция для назального применения с улучшенной стабильностью
UA113540C2 (xx) Поліморфи n-(2-метоксибензоїл)-4-$(метиламінокарбоніл)аміно]бензолсульфонаміду

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM